This is unpublished

CLEAR: Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease

Completed Studies
CKD
Pinned
Principal Investigator
Ian de Boer
Funding Agency
NIDDK
Status
Completed

Investigator

Ian de Boer, MD

 

 

 

Ian de Boer, MD, MS

what is the CLEAR study?

Subjects in this study will receive IV administration of vitamin D. We hope to understand better how the body uses vitamin D and how CKD and race affect it.

Publications

JASN: Differences in 25-Hydroxyvitamin D Clearance by eGFR and Race: A Pharmacokinetic Study 

The Journal of Steroid Biochemistry and Molecular Biology: Validation of the 24,25-dihydroxyvitamin D3 to 25-hydroxyvitamin D3 ratio as a biomarker of 25-hydroxyvitamin D3 clearance